Golden Sun Health Technology Group Limited — Form 6-K Summary
Business context and reporting period
Golden Sun Health Technology Group Limited filed a Form 6-K as a foreign private issuer for May 2024. The filing was dated May 7, 2024, and identifies the company’s principal executive offices in Shanghai, China. The company reports annual information on Form 20-F.
Key financial metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It consists primarily of a cover page and an exhibit index.
Material changes versus the prior comparable period
The filing does not provide comparative financial information or quantify changes from a prior period.
Guidance, outlook, risks, and unusual items
The filing identifies Exhibit 99.1 as a press release titled “Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement.” The underlying press release was not included in the provided filing text, so the specific Nasdaq requirement, timing, conditions, and management commentary cannot be verified from this material.
Important facts to verify
- Review Exhibit 99.1 to confirm the Nasdaq listing requirement that was restored and any continuing conditions or compliance deadlines.
- Confirm whether the company remains subject to additional Nasdaq compliance, delisting, or corporate-governance risks.
- Obtain the company’s latest Form 20-F or other financial filings for current revenue, profitability, cash flow, debt, liquidity, and operating trends.
- Verify the exact legal entity name, as the provided request metadata refers to “Golden Sun Technology Group Ltd.,” while the filing identifies “Golden Sun Health Technology Group Limited.”